Log in to save to my catalogue

Use of Next Generation Sequencing to Define the Origin of Primary Myelofibrosis

Use of Next Generation Sequencing to Define the Origin of Primary Myelofibrosis

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10046249

Use of Next Generation Sequencing to Define the Origin of Primary Myelofibrosis

About this item

Full title

Use of Next Generation Sequencing to Define the Origin of Primary Myelofibrosis

Publisher

Switzerland: MDPI AG

Journal title

Cancers, 2023-03, Vol.15 (6), p.1785

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Primary myelofibrosis (PMF) is a chronic myeloproliferative neoplasm (MPN) characterized by progressive bone marrow sclerosis, extra-medullary hematopoiesis, and possible transformation to acute leukemia. In the last decade, the molecular pathogenesis of the disease has been largely uncovered. Particularly, genetic and genomic studies have provided...

Alternative Titles

Full title

Use of Next Generation Sequencing to Define the Origin of Primary Myelofibrosis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10046249

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10046249

Other Identifiers

ISSN

2072-6694

E-ISSN

2072-6694

DOI

10.3390/cancers15061785

How to access this item